Defects in Cell-Mediated Immunity Affect Chronic, but Not Innate, Resistance of Mice to Mycobacterium avium Infection

Journal of Immunology

Volumn 158, Issue 10, 1997, Pages 4822-4831

  Doherty, T Mark ^a   Sher, A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANIMAL DISEASE; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; CELLULAR IMMUNITY; CHRONIC DISEASE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; LUNG; LYMPHOCYTE; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; MICROBIOLOGY; MOUSE; MOUSE MUTANT; MYCOBACTERIUM AVIUM; PHYSIOLOGY; SPLEEN; TIME; TUBERCULOSIS;

ANIMALS; CHRONIC DISEASE; CYTOKINES; GENE EXPRESSION; IMMUNITY, CELLULAR; INTERFERON TYPE II; LUNG; LYMPHOCYTES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, SCID; MYCOBACTERIUM AVIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RNA, MESSENGER; SPLEEN; TIME FACTORS; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031570043     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. D'Souza, S., M. Levin, A. Faith, H. Yssel, B. Bennett, R. A. Lake, I. N. Brown, and J. R. Lamb. 1996. Defective antigen processing associated with familial disseminated mycobacteriosis. Clin. Exp. Immunol. 103:35.
2. Holland, S. M., E. M. Eisenstein, D. B. Kuhns, M. L. Turner, T. A. Fleisher, W. Strober, and J. I. Gallin. 1994. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma: a preliminary report. N. Engl. J. Med. 330:1348.
3. Hawkins, C. C., J. W. Gold, E. Whimbey, T. E. Kiehn, P. Brannon, R. Cammarata, A. E. Brown, and D. Armstrong. 1986. Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann. Intern. Med. 105:184.
4. Young, L. S., C. B. Inderlied, O. G. Berlin, and M. S. Gottlieb. 1986. Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex. Rev. Infect. Dis. 8:1024.
5. Shiratsuchi, H., J. L. Johnson, and J. J. Ellner. 1994. Mycobacterium avium: pathogenicity in HIV1 infection. Res. Microbiol. 145:230.
6. Ellner, J. J., M. J. Goldberger, and D. M. Parenti. 1991. Mycobacterium avium and AIDS: a therapeutic dilemma in rapid evolution. J. Infect. Dis. 163:1326.
7. Baohong, J., L. Nacer, C. Truffot-Pernot, and J. Grossel. 1992. Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy. Antimicrob. Agents Chemother. 36:2839.
8. Kaufmann, S. H. E. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:129.
9. Ferreira, P., R. Soares, and C. M. Arala. 1991. Susceptibility to infection with Mycobacterium avium is paradoxically correlated with increased synthesis of specific anti-bacterial antibodies. Int. Immunol. 3:445.
10. Appelberg, R. 1994. Protective role of interferon gamma, tumor necrosis factor alpha and interleukin-6 in Mycobacterium tuberculosis and M. avium infections. Immunobiology 191:520.
11. Castro, A. G., R. A. Silva, and R. Appelberg. 1995. Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice. J. Immunol. 155:2013.
12. Kobayashi, K., T. Kasama, J. Yamazaki, M. Hosaka, T. Katsura, T. Mochizuki, K. Soejima, and R. M. Nakamura. 1995. Protection of mice from Mycobacterium avium infection by recombinant interleukin-12. Antimicrob. Agents Chemother. 39:1369.
13. Denis, M., and E. Ghadirian. 1993. IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections. J. Immunol. 151:5425.
14. Harshan, K. V., and P. R. Gangadharam. 1991. In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice. Infect. Immun. 59:2818.
15. Rastogi, N. 1990. Killing intracellular mycobacteria in in vitro macrophage systems: what may be the role of known host microbicidal mechanisms? Res. Microbiol. 141:217.
16. Blanchard, D. K. 1992. Cytokine activation of killer cells in mycobacterial immunity. Adv. Exp. Med. Biol. 319:105.
17. Bermudez, L. E. 1993. Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages: the role of nitric oxide. Clin. Exp. Immunol. 91:277.
18. + large granular lymphocytes in the induction of tumor necrosis factor by Mycobacterium avium-intracellulare complex. J. Leukocyte Biol. 50:529.
19. Crowle, A. J., A. Y. Tsang, A. E. Vatter, and M. H. May. 1986. Comparison of 15 laboratory and patient-derived strains of Mycobaclerium avium for ability to infect and multiply in cultured human macrophages. J. Clin. Microbiol. 24:812
20. Schaefer, W. B., C. L. Davis, and M. L. Cohn. 1970. Pathogenicity of transparent, opaque, and rough variants of Mycobacterium avium in chickens and mice. Am. Rev. Respir. Dis. 102:499.
21. Newman, G. W., H. X. Gan, P. J. McCarthy, and H. G. Remold. 1991. Survival of human macrophages infected with Mycobacterium avium intracellulare correlates with increased production of tumor necrosis factor-alpha and IL-6. J. Immunol. 147:3942.
22. Rose, R. M., J. M. Fuglestad, and L. Remington. 1991. Growth inhibition of Mycobacterium avium complex in human alveolar macrophages by the combination of recombinant macrophage colony-stimulating factor and interferon-gamma. Am. J. Respir. Cell Mol. Biol. 4:248.
23. Saunders, B. M., Y. Zhan, and C. Cheers. 1995. Endogenous interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection. Infect. Immun. 63:4011.
24. Saunders, B. M., and C. Cheers. 1995. Inflammatory response following intranasal infection with Mycobacterium avium complex: role of T-cell subsets and gamma interferon. Infect. Immun. 63:2282.
25. Bermudez, L. E., and L. S. Young. 1988. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J. Immunol. 140:3006.
26. Chan, J., K. Tanaka, D. Carroll, J. Flynn, and B. R. Bloom. 1995. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 63:736.
27. Liew, F. Y., and F. E. Cox. 1991. Nonspecific defence mechanism: the role of nitric oxide. Immunol. Today 12:17.
28. Scharton-Kersten, T. M., T. A. Wynn, E. Y. Denkers, S. Bala, E. Grunvald, S. Heiny, R. T. Gazzinelli, and A. Sher. 1996. In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157:4045.
29. MacMicking, J. D., C. Nathan, G. Hom, N. Chartrain, D. S. Fletcher, M. Trumbauer, K. Stevens, Q. W. Xie, K. Sokol, N. Hutchinson, H. Chen, and J. S. Mudgett. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase [published erratum appears in 1995 Cell 81:1170.] Cell 81:641.
30. Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. 1985. Measurement of protein using bicinchoninic acid [Published erratum appears in 1987 Anal. Biochem. 163:279.]. Anal. Biochem. 150:76.
31. Doherty, T. M., R. A. Seder, and A. Sher. 1996. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 156:735.
32. Doherty, T. M., and R. L. Coffman. 1993. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major. J. Immunol. 150:5476.
33. Klemens, S. P., M. A. Grossi, and M. H. Cynamon. 1994. Comparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complex. Antimicrob. Agents Chemother. 38:234.
34. Appelberg, R., A. G. Castro, S. Gomes, J. Pedrosa, and M. T. Silva. 1995. Susceptibility of beige mice to Mycobacterium avium: role of neutrophils. Infect. Immun. 63:3381.
35. Bermudez, L. E., P. Kolonoski, and L. S. Young. 1990. Natural killer cell activity and macrophage-dependem inhibition of growth or killing of Mycobacterium avium complex in a mouse model. J. Leukocyte Biol. 47:135.
36. Schurr, E., D. Malo, D. Radzioch, E. Buschman, K. Morgan, P. Gros, and E. Skamene. 1991. Genetic control of innate resistance to mycobacterial infections. Immunol. Today 12:456.
37. Castro, A. G., P. Minoprio, and R. Appelberg. 1995. The relative impact of bacterial virulence and host genetic background on cytokine expression during Mycobacterium avium infection of mice. Immunology 85:556.
38. Yamamura, M., X. H. Wang, J. D. Ohmen, K. Uyemura, T. H. Rea, B. R. Bloom, and R. L. Modlin. 1992. Cytokine patterns of immunologically mediated tissue damage. J. Immunol. 149:1470.
39. Doherty, T. M. 1995. T-cell regulation of macrophage function. Curr. Opin. Immunol. 7:400.
40. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in Interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243.
41. Appelberg, R., A. G. Castro, J. Pedrosa, R. A. Silva, I. M. Orme, and P. Minoprio. 1994. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection [Published erratum appears in 1995 Infect. Immun. 63:1145.]. Infect. Immun. 62:3962.
42. Liew, F. Y., Y. Li, and S. Millott. 1990. Tumor necrosis factor-alpha synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145:4306.
43. Oswald, I. P., T. A. Wynn, A. Sher, and S. L. James. 1994. NO as an effector molecule of parasite killing: modulation of its synthesis by cytokines. Comp. Biochem. Physiol. Pharmacol. Toxicol. Endocrinol. 108:11.
44. Tomioka, H., K. Sato, W. W. Maw, and H. Saito. 1995. The role of tumor necrosis factor, interferon-gamma, transforming growth factor-beta, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection. J. Leukocyte Biol. 58:704.
45. Tomioka, H., T. Kishimoto, and W. W. Maw. 1996. Phospholipids and reactive nitrogen intermediates collaborate in expression of the T cell mitogenesis-inhibitory activity of immunosuppressive macrophages induced in mycobacterial infection. Clin. Exp. Immunol. 103:219.
46. Shiratsuchi, H., Z. Toossi, M. A. Mettler, and J. J. Ellner. 1993. Colonial morphotype as a determinant of cytokine expression by human monocytes infected with Mycobacterium avium. J. Immunol 150:2945.
47. Saunders, B. M., Z. Liu, Y. Zhan, and C. Cheers. 1993. Interleukin-6 production during chronic experimental infection. Immunol. Cell Biol. 71:275.
48. Dumarey, C. H., V. Labrousse, N. Rastogi, B. B. Vargaftig, and M. Bachelet. 1994. Selective Mycobacterium avium-induced production of nitric oxide by human monocyte-derived macrophages. J. Leukocyte Biol. 56:36.
49. Takashima, T., and F. M. Collins. 1988. T-cell-mediated immunity in persistent Mycobacterium intracellulare infections in mice. Infect. Immun. 56:2782.
50. Florido, M., R. Appelberg, I. M. Orme, and A. M. Cooper. 1997. Evidence for a reduced chemokine response in the lungs of beige mice infected with Mycobacterium avium. Immunology. In press.
51. Denis, M., and E. Ghadirian. 1994. Interleukin-1 is involved in mouse resistance to Mycobacterium avium. Infect. Immun. 62:457.
52. Appelberg, R., A. Sarmento, and A. G. Castro. 1995. Tumour necrosis factor-alpha (TNF-alpha) in the host resistance to mycobacteria of distinct virulence. Clin. Exp. Immunol. 101:308.
53. Blanchard, D. K., M. B. Michelini-Norris, and J. Y. Djeu. 1991. Interferon decreases the growth inhibition of Mycobacterium avium-intracellulare complex by fresh human monocytes but not by culture-derived macrophages. J. Infect. Dis. 164:152.
54. Flesch, I. E., J. H. Hess, S. Huang, M. Aguet, J. Rome, H. Bluethmann, and S. H. Kaufmann. 1995. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J. Exp. Med. 181:1615.
55. Cella, M., D. Sheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747.
56. Sarmento, A. M., and R. Appelberg. 1995. Relationship between virulence of Mycobacterium avium strains and induction of tumor necrosis factor alpha production in infected mice and in in vitro-cultured mouse macrophages. Infect. Immun. 63:3759.
57. Gan, H., G. W. Newman, and H. G. Remold. 1995. Human macrophages acquire a hyporesponsive state of tumor necrosis factor alpha production in response to successive Mycobacterium avium serovar 4 stimulation. Infect. Immun. 63:1921.
58. Greenberg, S. S., J. Xie, J. Kolls, C. Mason, and P. Didier. 1995. Rapid induction of mRNA for nitric oxide synthase II in rat alveolar macrophages by intratracheal administration of Mycobacterium tuberculosis and Mycobacterium avium. Proc. Soc. Exp. Biol. Med. 209:46.
59. David, H. L., N. Rastogi, S. S. Clavel, F. Clement, and M. F. Thorel. 1987. Structure of the cell envelope of Mycobacterium avium. Zentralbl. Bakteriol. [A] 264:49.
60. Frehel, C., A. Ryter, N. Rastogi, and H. David. 1986. The electron-transparent zone in phagocytized Mycobacterium avium and other mycobacteria: formation, persistence and role in bacterial survival [published erratum appears in 1987 Ann. Inst. Pasteur Microbiol. 138:147.]. Ann. Inst. Pasteur Microbiol. 137:239.
61. Bermudez, L. E., M. Wu, and L. S. Young. 1995. Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium. Infect. Immun. 63:4099.
62. Hsu, N., L. S. Young, and L. E. Bermudez. 1995. Response to stimulation with recombinant cytokines and synthesis of cytokines by murine intestinal macrophages infected with the Mycobacterium avium complex. Infect. Immun. 63:528.
63. Pedrosa, J., M. Florido, Z. M. Kunze, A. G. Castro, F. Portaels, J. McFadden, M. T. Silva, and R. Appelberg. 1994. Characterization of the virulence of My cobacterium avium complex (MAC) isolates in mice. Clin. Exp. Immunol. 98: 210.
64. Denis, M. 1991. Growth of Mycobacterium avium in human monocytes: identification of cytokines which reduce and enhance intracellular microbial growth. Eur. J. Immunol. 21:391.
65. Appelberg, R., and I. M. Orme. 1993. Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages. Immunology 80:352.
66. Sternberg, J., and F. McGuigan. 1992. Nitric oxide mediates suppression of T cell responses in murine Trypanosoma brucei infection. Eur. J. Immunol. 22:2741.
67. Al-Ramadi, B. K., J. J. J. Meissler, D. Huang, and T. K. Eisenstein. 1992. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur. J. Immunol. 22:2249.